国际共识:标准化克罗恩病小肠狭窄的组织病理学评分
该国际共识采用改良RAND/UCLA方法,由专家组评估313项候选条目,旨在标准化克罗恩病小肠狭窄的组织病理学评分。共识定义了初发和吻合口狭窄的诊断标准及活动性与慢性黏膜炎症的组织学定义,并认为现有评分系统均不适合临床试验。标准化评估有望提高临床试验效率并促进药物开发。
要点
- 狭窄诊断需肠壁增厚、管腔直径或内周长减小及黏膜下层纤维化。
- 组织学狭窄定义为肠壁全层增厚、黏膜下层及肠壁纤维化、黏膜下层肌化。
- 现有评估CD狭窄的评分系统均不适合临床试验。
核心结论
- 标准化克罗恩病小肠狭窄的大体病理和组织病理学评估将提高临床试验效率并助力药物开发。
研究设计与样本
- 采用改良RAND/UCLA适宜性方法,由专家组评估313项与克罗恩病小肠狭窄评估相关的候选条目。
主要发现
- 初发和吻合口狭窄的诊断需肠壁增厚、管腔直径或内周长减小及黏膜下层纤维化。
- 组织学狭窄定义为肠壁全层增厚、黏膜下层及肠壁纤维化、黏膜下层肌化。
- 活动性黏膜炎症定义为固有层及任何隐窝或完整表面上皮的中性粒细胞浸润、糜烂、溃疡和瘘管。
- 慢性黏膜炎症定义为隐窝结构扭曲和丢失、幽门腺化生、潘氏细胞增生、基底部淋巴浆细胞增多、浆细胞增多和纤维化,或黏膜/黏膜下层界面明显的淋巴聚集。
- 用于评估CD狭窄的评分系统均被认为不适合临床试验。
关键数值与推荐
- 狭窄诊断标准:肠壁增厚、管腔直径或内周长减小、黏膜下层纤维化。
- 组织学狭窄标准:肠壁全层增厚、黏膜下层及肠壁纤维化、黏膜下层肌化。
- 活动性黏膜炎症标准:固有层及任何隐窝或完整表面上皮的中性粒细胞浸润、糜烂、溃疡、瘘管。
- 慢性黏膜炎症标准:隐窝结构扭曲和丢失、幽门腺化生、潘氏细胞增生、基底部淋巴浆细胞增多、浆细胞增多和纤维化,或黏膜/黏膜下层界面明显的淋巴聚集。
临床怎么用
- 临床 trials 中应采用共识定义标准化评估小肠狭窄的组织病理学。
- 现有评分系统不适用于临床试验,需开发新工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Effective medical therapy and validated trial outcomes are lacking for small bowel Crohn's disease (CD) strictures. Histopathology of surgically resected specimens is the gold standard for correlation with imaging techniques. However, no validated histopathological scoring systems are currently available for small bowel stricturing disease. We convened an expert panel to evaluate the appropriateness of histopathology scoring systems and items generated based on panel opinion. DESIGN: Modified RAND/University of California Los Angeles methodology was used to determine the appropriateness of 313 candidate items related to assessment of CD small bowel strictures. RESULTS: In this exercise, diagnosis of naïve and anastomotic strictures required increased bowel wall thickness, decreased luminal diameter or internal circumference, and fibrosis of the submucosa. Specific definitions for stricture features and technical sampling parameters were also identified. Histopathologically, a stricture was defined as increased thickness of all layers of the bowel wall, fibrosis of the submucosa and bowel wall, and muscularisation of the submucosa. Active mucosal inflammatory disease was defined as neutrophilic inflammation in the lamina propria and any crypt or intact surface epithelium, erosion, ulcer and fistula. Chronic mucosal inflammatory disease was defined as crypt architectural distortion and loss, pyloric gland metaplasia, Paneth cell hyperplasia, basal lymphoplasmacytosis, plasmacytosis and fibrosis, or prominent lymphoid aggregates at the mucosa/submucosa interface. None of the scoring systems used to assess CD strictures were considered appropriate for clinical trials. CONCLUSION: Standardised assessment of gross pathology and histopathology of CD small bowel strictures will improve clinical trial efficiency and aid drug development.
引用
- Gordon IO, Bettenworth D, Bokemeyer A, et al. International consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease. Gut. 2021. PMID: 33952604. doi:10.1136/gutjnl-2021-324374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。